The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- OneOncology and OpenEvidence Partner to Improve Cancer Care Nationwide (OneOncology)
- FIT-Based Screening Linked to Drop in Colorectal Cancer Mortality (Medpage Today)
- Vedanta Biosciences Secures $60 Million in Funding and Strengthens Leadership Team Ahead of Pivotal Phase 3 Data (Business Wire)
- The physician opportunity cost nobody puts on a bill (KevinMD)
- A ‘molecular switch’ that heals the gut—and that colorectal cancer hijacks to spread (Medical Xpress)
- Why gastroenterology is especially exposed to predatory contracts, GI says (Becker’s GI & Endoscopy)
- The Microbiome Is Not a Bar Code
- Not All False-Positive Stool DNA Tests Should be Dismissed (GI & Endoscopy News)
